OPTION CARE HEALTH INCOPCH
ASignal's systematic analysis rates OPCH as Neutral.
Reflects the latest available analysis · analyzed Sep 4, 2026
The case on OPCH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Forward P/E of 11.75x suggests valuation discount relative to current earnings
- Return on Equity of 16.00% indicates strong capital efficiency
- Positive earnings growth of 12.90% year-over-year
- Free cash flow of $256.07M supports operational strength
- EV/Revenue of 0.83x below sector average, indicating potential undervaluation
- Revenue growth at 1.90% is minimal, indicating limited top-line expansion
- Gross margin of 19.06% is moderate for Healthcare sector
- Debt-to-equity ratio of 1.01x indicates elevated leverage
- Quick ratio of 0.91x suggests near-term liquidity pressure
- No Reddit mentions, indicating low retail investor interest or visibility
See the full verdict on OPCH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes OPCH
Most investors never get a second opinion, let alone several. ASignal runs OPCH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.